Vowst™ (fecal microbiota spores live-brpk)
Full Name | Vowst™ (fecal microbiota spores live-brpk) |
Drug | Vowst |
Manufacturer | Aimmune Therapeutics |
Route of Administration | Oral |
Site of Care | Home |
Approved Indication | Prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI) |
Disease | Recurrent C. difficile Infection (rCDI) |
Therapeutic Area | Infectious Disease; Gastroenterology |
Enrollment Form Link | Vowst Enrollment Form |
Phone Number | 800-485-4885 |
Fax Number | 877-640-5179 |
Product Website | vowsthcp.com |